Case Report
aneurysm was then excluded with stent grafts (three balloon mounted stent grafts, Life Stream-BARD-6 mm × 58 mm, 6 mm × 37 mm, 5 mm × 37 mm) [ Figure 3 ] with adequate overlap between them. Poststenting angiogram showed no endoleak [ Figure 3 ], with good flow in SMA and distal branches. He made an uneventful recovery and remains asymptomatic at the 6 th month follow-up. The duplex scan showed complete exclusion of proximal aneurysm and no endoleak. He continues to be on regular surveillance for the smaller distal SMA aneurysm.
dIScUSSIOn
VAAs and pseudoaneurysms are associated with a significant risk of rupture and death. [5, 6] These are rare and account for 5.5% of all VAAs (combined degenerative, inflammatory, connective tissue disorder, etc.). Hence, large studies documenting their outcomes are lacking in the literature. [7] Both sexes are equally affected, with a higher risk of rupture in males. [2] Most patients with mycotic aneurysms are under 50 years of age, and patients with atherosclerotic aneurysms are usually in their seventh or eighth decades. [8] In a series from the Mayo Clinic reported in 2002, only 5% of patients were thought to have an infection as the primary cause, whereas 62% were secondary to atherosclerosis. [2] This is also validated in more recent reports. [9] Search results using PubMed, Cochrane Library, Medline, and Medscape research databases, about SMA case series and individual management of the SMA are tabulated in Table 1 .
Stone et al. [2] in their study reported in their series that 48% of all patients were asymptomatic, and in the study by Jiang et al. it was about 70%. [9] Two important reasons of increased incidence of asymptomatic SMAAs are increased use of CT scan for other diagnostic purpose and widespread use of antibiotics which could potentially prevent an infectious cause of SMAAs. [2, 10, 11] Symptomatic patients may present with abdominal pain, nausea, vomiting, and pulsatile mass or gastrointestinal bleeding. The acute presentation can be with a picture of hemorrhagic shock secondary to rupture or with features of small bowel ischemia caused by thrombosis in 38% and carries mortality risk of 35%. [2, 10] The indications for repair include SMAAs with a diameter >2 cm, symptomatic and rapidly growing SMAA. Controversies persist regarding the absolute indications. [12, 13] De Bakey and Cooley described the first successful resection without revascularization of a mycotic SMAA caused by bacterial endocarditis in a young female in 1953. [14] Open surgical repair is considered as "gold standard" for all SMAAs in patients who require intervention. It can be performed by surgical resection with arterial reconstruction, or by ligation of the vessel without reconstruction. [15] The evolution of endovascular techniques has also impacted the management of visceral artery aneurysms. In general, the minimally invasive procedures are associated with less morbidity and mortality (4.6% in open repair vs. 1.2% in an endovascular repair-randomized study done on 354 patients), shorter hospitalization, fewer complications, and a better perioperative quality of life. [16] Endovascular treatment also plays an important role in the emergent treatment of ruptured SMAAs with technical success rates up to 90%. [17] In the current literature, there are only a few case reports and small case series that report the use of endovascular treatment of SMAAs. [2, 9, 17, 18] Conservative management of the aneurysm is not well documented although Stone et al., [2] have managed 6 patients with 67 months follow-up and Ray et al. [19] managed 1 case for 11 years. Beta-blockers have some protective effect and can be used when patients are reluctant for surgery. [19] Aneurysms with diameter <20 mm are considered to have a low rupture rate [20] and can be managed conservatively with close follow-up, although one group reported aneurysm size as a nonreliable predictor of rupture. [21] The current follow-up protocol proposed for the endovascular management of visceral aneurysms includes imaging (duplex scan) at 3-month intervals during the 1 st year and annually thereafter. [17] Future studies are still needed to show the long-term results of stenting or coil embolization of SMAAs before it can be considered a safe and effective treatment.
cOnclUSIOn SMAAs remain a rare entity with a wide range of clinical presentation. High rupture and other complication rates are associated with SMAAs, and hence, early treatment is recommended for symptomatic, rapidly growing, and relatively large SMAAs. Open repair, primarily ligation, and excision of the aneurysm, remains the gold standard, but recent studies indicate that the endovascular management is feasible, but it seems unlikely to have large series, since these are rare entities.
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